Literature DB >> 19149574

Structure of cytochrome p450s and personalized drug.

Jing-Fang Wang1, Cheng-Cheng Zhang, Kuo-Chen Chou, Dong-Qing Wei.   

Abstract

Cytochrome P450s are the most important enzymes responsible for phase I drug metabolism. The polymorphic nature of cytochrome P450s largely influences individual drug responses, drug-drug interactions and induces adverse drug reactions. By far, thirty crystal structures of eight mammalian cytochrome P450s (CYP 2C5, 2C8, 2C9, 3A4, 2D6, 2B4, 2A6 and 1A2) have been published. This review focuses on the recent studies on the structures of cytochrome P450s: some characteristic features of these enzymes and many essential, conserved amino acids in the active sites have been identified. These results are of fundamental importance for drug development and understanding the metabolism for both endogenous and xenobiotic substrates. With the help of computational methods, the structural information will provide insights into personalization of drug treatments in both proper drug therapy and appropriate dosage of a certain drug.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149574     DOI: 10.2174/092986709787002727

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  14 in total

1.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

2.  Exploration of conformational transition in the aryl-binding site of human FXa using molecular dynamics simulations.

Authors:  Jing-Fang Wang; Pei Hao; Yi-Xue Li; Jian-Liang Dai; Xuan Li
Journal:  J Mol Model       Date:  2011-11-25       Impact factor: 1.810

3.  Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data.

Authors:  Hongmao Sun; Henrike Veith; Menghang Xia; Christopher P Austin; Ruili Huang
Journal:  J Chem Inf Model       Date:  2011-09-26       Impact factor: 4.956

4.  Predicting drug-target interaction networks based on functional groups and biological features.

Authors:  Zhisong He; Jian Zhang; Xiao-He Shi; Le-Le Hu; Xiangyin Kong; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

5.  Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks.

Authors:  Tao Huang; Xiao-He Shi; Ping Wang; Zhisong He; Kai-Yan Feng; Lele Hu; Xiangyin Kong; Yi-Xue Li; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

6.  Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice.

Authors:  Andrew A Monte; Vasilis Vasiliou; Kennon J Heard
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2012-03-16

7.  The role of hepatic cytochrome P-450 in sepsis.

Authors:  Asha Jacob; Mian Zhou; Rongqian Wu; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2009-08-25

8.  Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs.

Authors:  Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

9.  IN VIVO EFFECT OF RUTA CHALEPENSIS EXTRACT ON HEPATIC CYTOCHROME 3A1 IN RATS.

Authors:  Edith Fabiola Martínez-Pérez; Fernando Hernández-Terán; Luis Benjamín Serrano-Gallardo
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

10.  Chicken cytochrome P450 1A5 is the key enzyme for metabolizing T-2 toxin to 3'OH-T-2.

Authors:  Shufeng Shang; Jun Jiang; Yiqun Deng
Journal:  Int J Mol Sci       Date:  2013-05-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.